IGM Biosciences, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
IGMS on Nasdaq
Industry
Pharmaceutical Preparations
Location
325 E Middlefield Road, Mountain View, CA

Insiders trading volume in the past year

IGM Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Holding A/S Topsoe 10%+ Owner $40.4M Jun 26, 2023
Jakob Haldor Topsoe Director, 10%+ Owner $12.9M Mar 31, 2025
Fred Schwarzer CEO AND PRESIDENT, Director $5.16M -$77.1K -1.47% Sep 13, 2024
Baker Bros. Advisors Lp Director, 10%+ Owner $4.63M Mar 31, 2025
Redmile Group, LLC Director, 10%+ Owner $3.65M Mar 31, 2025
Bruce Keyt Chief Scientific Officer $2.85M -$25.5K -0.89% Sep 13, 2024
Chris H. Takimoto Chief Medical Officer $1.78M -$29.1K -1.61% Sep 13, 2024
William Strohl Director $1.75M Aug 8, 2024
Daniel ShinYu Chen Chief Medical Officer $769K Jul 1, 2021
Mary Beth Harler Chief Executive Officer, Director $418K -$50.8K -10.8% Mar 14, 2025
George Gauthier Chief Commercial Officer $262K Nov 29, 2023
Michael D. Loberg Director $231K Sep 29, 2023
Misbah Tahir Chief Financial Officer $222K -$50.8K -18.6% Mar 14, 2025
Lisa Lynn Decker Chief Business Officer $90.4K -$31.6K -25.9% Mar 14, 2025
Christina Teng Topsoe Director, 10%+ Owner $77.2K Mar 31, 2025
M. Kathleen Behrens Director $62.2K Mar 31, 2025
Steven Weber Principal Accounting Officer $35.5K -$17.2K -32.6% Mar 14, 2025
Julie Hambleton Director $28K -$212K -88.3% Jul 25, 2024
Michael Lee Director $14.6K Mar 31, 2025
Elizabeth H.Z. Thompson Director $8K Mar 31, 2025

Recent Insider Transactions by Companies or Individuals for IGM Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.